Pharmacy purchase
Ended Awarded Last action
- Contract number
- 36C25926F0068
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Horsham, PA 19044, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$351,988 | |
| Original award | $351,988 |
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 19, awarded a $351,987.69 firm fixed-price delivery order to Janssen Biotech Inc. (doing business as Centocor Ortho Biotech Inc.) on December 16, 2025, for pharmacy purchases to be performed in Horsham, PA. This delivery order, with an ultimate completion date of January 16, 2026, carries no set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Janssen Biotech, a Johnson & Johnson subsidiary specializing in biologic therapies and oncology medications, provides critical pharmaceutical products to support the VA's healthcare services for veterans nationwide.
This delivery order is issued against Janssen Biotech's existing Blanket Purchase Agreement with the VA valued at $15 million (completion date September 19, 2026) and its multiple-award Federal Supply Schedule contract for Pharmaceuticals and Drugs valued at $6.8 billion (completion date August 31, 2029). The company's federal contract portfolio focuses exclusively on oncology medications, including specialized drugs such as BALVERSA (erdafitinib), CARVYKTI, and WELIREG, which are delivered to various Veterans Integrated Service Networks to ensure a consistent and reliable supply of essential pharmaceutical products for veteran healthcare programs.
Quick answers
Who was awarded contract 36C25926F0068?
36C25926F0068 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on December 16, 2025.
How much is contract 36C25926F0068 worth?
The government has obligated $0 on 36C25926F0068.
Is contract 36C25926F0068 an order under another contract?
Yes. 36C25926F0068 is a delivery order under 36F79724D0176, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25926F0068 competed?
The extent of competition for 36C25926F0068 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award